The Construction and Characterization of Layered Double Hydroxides As Delivery Vehicles for Podophyllotoxins

Overview

Journal J Mater Sci Mater Med

Publisher Springer

Specialty Biomedical Engineering

Date 2007 Aug 19

PMID 17701296

Citations 4

Authors

Yan Hua Xue

Rui Zhang

Xiao Yu Sun

Shi Long Wang

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to construct PPT-LDH nanohybrids and compare their tumor inhibition effects with that of free PPT. Anticancer drug podophyllotoxin (PPT) was encapsulated in the galleries of Mg-Al layered double hydroxides (LDHs) by a two-step approach. Tyrosine (Tyr) was first incorporated into the interlayer space by co-precipitation with LDH, prop-opening the layers of Mg-Al/LDH and creating an interlayer environment inviting drug molecules. PPT was subsequently intercalated into the resulting material lamella by an ion exchange process. The intermediate and final products, which can be termed drug-inorganic nanocomposites, have been characterized by powder X-ray diffraction (XRD), UV-VIS spectrophotometer, transmission electron microscopy (TEM) and in cell culture. Our results demonstrate that the interlayer spacing distance of the PPT-LDH nanohybrids (34% w/w of drug/material) is 18.2 A. LDHs do not harm normal cells (293T) based on toxicity tests. Ex-vivo anticancer experiments reveal that the PPT-LDH nanohybrids have higher tumor suppression effects than intercalated PPT. We conclude that the higher tumor inhibition effects of PPT-LDH hybrids result from the inorganic drug delivery vehicle, LDHs.

Citing Articles

Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane.

Yan M, Zhang Z, Cui S, Lei M, Zeng K, Liao Y Int J Nanomedicine. 2014; 9:4867-78.

PMID: 25364245 PMC: 4211912. DOI: 10.2147/IJN.S69729.

Potential for layered double hydroxides-based, innovative drug delivery systems.

Zhang K, Xu Z, Lu J, Tang Z, Zhao H, Good D Int J Mol Sci. 2014; 15(5):7409-28.

PMID: 24786098 PMC: 4057680. DOI: 10.3390/ijms15057409.

The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids.

Qin L, Wang M, Zhu R, You S, Zhou P, Wang S Int J Nanomedicine. 2013; 8:2053-64.

PMID: 23737669 PMC: 3668966. DOI: 10.2147/IJN.S43203.

The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles.

Wang M, Qin L, Li K, Zhu R, Wang W, Wang S AAPS PharmSciTech. 2012; 13(4):1348-54.

PMID: 23054988 PMC: 3513471. DOI: 10.1208/s12249-012-9862-8.

References

Choy J, Jung J, Oh J, Park M, Jeong J, Kang Y . Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials. 2004; 25(15):3059-64. DOI: 10.1016/j.biomaterials.2003.09.083. View

Shah J, Chen J, Chow D . Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res. 1989; 6(5):408-12. DOI: 10.1023/a:1015935532725. View

Gordijo C, Barbosa C, da Costa Ferreira A, Constantino V, de Oliveira Silva D . Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides. J Pharm Sci. 2005; 94(5):1135-48. DOI: 10.1002/jps.20336. View

Ledley F . Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther. 1995; 6(9):1129-44. DOI: 10.1089/hum.1995.6.9-1129. View

Imbert T . Discovery of podophyllotoxins. Biochimie. 1998; 80(3):207-22. DOI: 10.1016/s0300-9084(98)80004-7. View

Choy , Kwak , Jeong , Park . Inorganic Layered Double Hydroxides as Nonviral Vectors This work was in part supported by the Korean Ministry of Science and Technology through the NRL project and by the Korean Ministry of Education (BSRI-99-3413). S.Y.K. expresses her thanks to.... Angew Chem Int Ed Engl. 2000; 39(22):4041-4045. DOI: 10.1002/1521-3773(20001117)39:22<4041::aid-anie4041>3.0.co;2-c. View

Peterson C, Perry D, Masood H, Lin H, White J, Hem S . Characterization of antacid compounds containing both aluminum and magnesium. I. Crystalline powders. Pharm Res. 1993; 10(7):998-1004. DOI: 10.1023/a:1018958621782. View

Hainsworth J, Williams S, Einhorn L, Birch R, Greco F . Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial. J Clin Oncol. 1985; 3(5):666-71. DOI: 10.1200/JCO.1985.3.5.666. View

Kokot Z . Studies of neutralizing properties of antacid preparations. Part 3: Constant pH neutralization of hydrochloric acid by hydrotalcite. Pharmazie. 1988; 43(4):249-51. View

10.

Van Maanen J, Retel J, de Vries J, Pinedo H . Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst. 1988; 80(19):1526-33. DOI: 10.1093/jnci/80.19.1526. View

11.

Slevin M . The clinical pharmacology of etoposide. Cancer. 1991; 67(1 Suppl):319-29. DOI: 10.1002/1097-0142(19910101)67:1+<319::aid-cncr2820671319>3.0.co;2-d. View

12.

Nakayama H, Wada N, Tsuhako M . Intercalation of amino acids and peptides into Mg-Al layered double hydroxide by reconstruction method. Int J Pharm. 2004; 269(2):469-78. DOI: 10.1016/j.ijpharm.2003.09.043. View

13.

Ambrogi V, Fardella G, Grandolini G, Perioli L . Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents--I. Intercalation and in vitro release of ibuprofen. Int J Pharm. 2001; 220(1-2):23-32. DOI: 10.1016/s0378-5173(01)00629-9. View

14.

Davis S . Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. Trends Biotechnol. 1997; 15(6):217-24. DOI: 10.1016/S0167-7799(97)01036-6. View

15.

Tyner K, Schiffman S, Giannelis E . Nanobiohybrids as delivery vehicles for camptothecin. J Control Release. 2004; 95(3):501-14. DOI: 10.1016/j.jconrel.2003.12.027. View